{"transactions":[{"id":1182854,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":81213,"kind":"person","name":"Donhauser Peter D.O.","position":1,"cik":"0001698234","reported_name":"Donhauser Peter D.O.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-03T01:47:21.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in three equal annual installments beginning on March 31, 2026"}],"balance_after":50000,"derivative":{"exercise_price":8.58,"expiration_date":"2035-03-31","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001731122-25-000518","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112225000518/ownership.xml","form_type":"4"}},{"id":1477009,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":81213,"kind":"person","name":"Donhauser Peter D.O.","position":1,"cik":"0001698234","reported_name":"Donhauser Peter D.O.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-17T11:30:10.000Z","date":"2024-06-14","kind":"purchase","planned":false,"acquired":true,"shares":2835,"price":3.64,"value":10319.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Purchase price denominated in Euros has been translated to US dollars using an exchange rate of 0.936"}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001731122-24-000957","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112224000957/ownership.xml","form_type":"4"}},{"id":1622132,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":81213,"kind":"person","name":"Donhauser Peter D.O.","position":1,"cik":"0001698234","reported_name":"Donhauser Peter D.O.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-23T11:05:18.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest in equal installments over three years from the grant date."}],"balance_after":50000,"derivative":{"exercise_price":5.36,"exercise_date":"2025-02-20","expiration_date":"2034-02-20","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001731122-24-000297","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112224000297/ownership.xml","form_type":"4"}},{"id":1927246,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":81213,"kind":"person","name":"Donhauser Peter D.O.","position":1,"cik":"0001698234","reported_name":"Donhauser Peter D.O.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-04T21:30:44.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest in equal instalments over three years from the grant date"}],"balance_after":50000,"derivative":{"exercise_price":8.57,"exercise_date":"2024-03-31","expiration_date":"2033-03-31","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001731122-23-000582","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112223000582/ownership.xml","form_type":"4"}},{"id":2219255,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":81213,"kind":"person","name":"Donhauser Peter D.O.","position":1,"cik":"0001698234","reported_name":"Donhauser Peter D.O.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-29T21:12:13.000Z","date":"2022-06-27","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":50000,"derivative":{"exercise_price":10.09,"exercise_date":"2023-06-27","expiration_date":"2032-06-27","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001731122-22-001145","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112222001145/ownership.xml","form_type":"4"}},{"id":2614486,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":81213,"kind":"person","name":"Donhauser Peter D.O.","position":1,"cik":"0001698234","reported_name":"Donhauser Peter D.O.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-04T21:30:37.000Z","date":"2021-08-02","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25000,"derivative":{"exercise_price":18.11,"exercise_date":"2022-08-02","expiration_date":"2031-08-02","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001731122-21-001300","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112221001300/ownership.xml","form_type":"4"}},{"id":2705078,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":81213,"kind":"person","name":"Donhauser Peter D.O.","position":1,"cik":"0001698234","reported_name":"Donhauser Peter D.O.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-19T12:47:25.000Z","date":"2021-05-17","kind":"purchase","acquired":true,"shares":1000,"price":10.93,"value":10930.0,"ownership":{"direct":true},"balance_after":2165,"source":{"system":"sec-edgar","filing":"0001731122-21-000916","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112221000916/ownership.xml","form_type":"4"}},{"id":2838694,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":81213,"kind":"person","name":"Donhauser Peter D.O.","position":1,"cik":"0001698234","reported_name":"Donhauser Peter D.O.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-23T18:22:55.000Z","date":"2021-02-19","kind":"purchase","acquired":true,"shares":165,"price":12.97,"value":2140.05,"ownership":{"direct":true},"balance_after":1165,"source":{"system":"sec-edgar","filing":"0001731122-21-000286","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112221000286/ownership.xml","form_type":"4"}},{"id":2838693,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":81213,"kind":"person","name":"Donhauser Peter D.O.","position":1,"cik":"0001698234","reported_name":"Donhauser Peter D.O.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-23T18:22:55.000Z","date":"2021-02-19","kind":"purchase","acquired":true,"shares":1000,"price":12.62,"value":12620.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001731122-21-000286","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112221000286/ownership.xml","form_type":"4"}},{"id":2925165,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":81213,"kind":"person","name":"Donhauser Peter D.O.","position":1,"cik":"0001698234","reported_name":"Donhauser Peter D.O.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-04T19:24:41.000Z","date":"2020-12-30","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":35000,"derivative":{"exercise_price":5.49,"exercise_date":"2021-12-30","expiration_date":"2030-12-30","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001731122-21-000010","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112221000010/ownership.xml","form_type":"4"}},{"id":3315103,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":81213,"kind":"person","name":"Donhauser Peter D.O.","position":1,"cik":"0001698234","reported_name":"Donhauser Peter D.O.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-08T23:00:14.000Z","date":"2020-01-06","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":50000,"derivative":{"exercise_price":2.96,"exercise_date":"2021-01-06","expiration_date":"2030-01-06","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001731122-20-000019","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112220000019/ownership.xml","form_type":"4"}},{"id":3798139,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":81213,"kind":"person","name":"Donhauser Peter D.O.","position":1,"cik":"0001698234","reported_name":"Donhauser Peter D.O.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-10-03T21:27:14.000Z","date":"2018-10-01","kind":"grant","acquired":true,"shares":45500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest upon the achievement of 50% enrollment in the Company's Alzheimer's disease and Parkinson's disease dementia clinical trials."}],"balance_after":45500,"derivative":{"exercise_price":2.58,"expiration_date":"2028-10-01","underlying":"Common Stock","underlying_shares":45500},"source":{"system":"sec-edgar","filing":"0001615774-18-010436","document":"s113103_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000161577418010436/s113103_form4.xml","form_type":"4"}}]}